{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:23:20Z","timestamp":1791235400213,"version":"4.1.0"},"reference-count":61,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2022,4,3]]},"DOI":"10.1080\/03007995.2022.2037846","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T08:58:01Z","timestamp":1644224281000},"page":"613-627","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Impact of switching to infliximab biosimilars on treatment patterns among US veterans receiving innovator infliximab"],"prefix":"10.1080","volume":"38","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0176-4435","authenticated-orcid":false,"given":"Iris","family":"Lin","sequence":"first","affiliation":[{"name":"Janssen Scientific Affairs, LLC, Horsham, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8378-5186","authenticated-orcid":false,"given":"Richard","family":"Melsheimer","sequence":"additional","affiliation":[{"name":"Janssen Biologics BV, Leiden, the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Bhak","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Lefebvre","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maral","family":"DerSarkissian","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0060-765X","authenticated-orcid":false,"given":"Bruno","family":"Emond","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Montr\u00e9al, Qu\u00e9bec, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Lax","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nguyen","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Los Angeles, California, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7928-0126","authenticated-orcid":false,"given":"Melody","family":"Wu","sequence":"additional","affiliation":[{"name":"Analysis Group, Inc, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinong","family":"Young-Xu","sequence":"additional","affiliation":[{"name":"White River Junction VA Medical Center, White River Junction, VT, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2022,2,18]]},"reference":[{"key":"CIT0001","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-015-0256-7"},{"key":"CIT0002","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-017-3726-1"},{"key":"CIT0003","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2016.10.039"},{"key":"CIT0004","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2006.052688"},{"key":"CIT0005","doi-asserted-by":"publisher","DOI":"10.1038\/nrgastro.2009.238"},{"key":"CIT0006","unstructured":"Janssen Pharmaceutical Companies. REMICADE (infliximab) Highlights of Prescribing Information. 2018. p. 1\u201321."},{"key":"CIT0007","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S207246"},{"key":"CIT0008","unstructured":"Food and Drug Administration (FDA). Biosimilar and Interchangeable Products 2017. [cited 2019 December 17]. Available from: https:\/\/www.fda.gov\/drugs\/biosimilars\/biosimilar-and-interchangeable-products."},{"key":"CIT0009","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2016.01.001"},{"key":"CIT0010","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-016-0201-6"},{"key":"CIT0011","unstructured":"CELLTRION, Inc. INFLECTRA\u00ae (infliximab-dyyb) Highlights of Prescribing Information. 2019. p. 1\u201343."},{"key":"CIT0012","unstructured":"CELLTRION I. INFLECTRA\u00ae (infliximab-dyyb) Highlights of Prescribing Information 2019."},{"key":"CIT0013","unstructured":"Inc A. AVSOLA (infliximab-axxq) Highlights of Prescribing Information 2019."},{"key":"CIT0014","unstructured":"Co SB. RENFLEXIS (infliximab-abda) Highlights of Prescribing Information. 2019."},{"key":"CIT0015","unstructured":"Pharmaceuticals PI. IXIFI (infliximab-qbtx) Highlights of Prescribing Information. 2020."},{"key":"CIT0016","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2019.1571296"},{"key":"CIT0017","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30068-5"},{"key":"CIT0018","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2017-211741"},{"key":"CIT0019","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.10.002"},{"key":"CIT0020","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2016.1198765"},{"key":"CIT0021","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210742"},{"key":"CIT0022","doi-asserted-by":"publisher","DOI":"10.1002\/art.40324"},{"key":"CIT0023","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2017.10.003"},{"key":"CIT0024","doi-asserted-by":"publisher","DOI":"10.5414\/CP203474"},{"key":"CIT0025","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-017-0085-z"},{"key":"CIT0026","doi-asserted-by":"publisher","DOI":"10.1007\/s40744-019-00190-7"},{"key":"CIT0027","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S285610"},{"key":"CIT0028","unstructured":"Johnson JAJ, Curtis JR, Pinnell DK, et\u00a0al. P1570: Infliximab Biosimilar use for Inflammatory Bowel Disease: A National Veterans Affairs Experience. ACG 2020. Annual Scientific Meeting; Virtual2020."},{"key":"CIT0029","doi-asserted-by":"publisher","DOI":"10.2147\/CLEP.S147175"},{"key":"CIT0030","doi-asserted-by":"publisher","DOI":"10.1016\/0021-9681(87)90171-8"},{"key":"CIT0031","doi-asserted-by":"publisher","DOI":"10.2147\/BTT.S172337"},{"issue":"2","key":"CIT0032","first-page":"835.1","volume":"76","author":"Phillips K","year":"2017","journal-title":"Annals Rheumatic Dis"},{"key":"CIT0033","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2018.11.002"},{"key":"CIT0034","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-020-00409-y"},{"key":"CIT0035","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2020-218412"},{"key":"CIT0036","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.30.1.69"},{"issue":"2","key":"CIT0037","first-page":"831","volume":"76","author":"Alten R","year":"2017","journal-title":"Annals Rheumatic Dis"},{"key":"CIT0038","doi-asserted-by":"publisher","DOI":"10.1080\/03007995.2018.1560221"},{"key":"CIT0039","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-018-2418-4"},{"key":"CIT0040","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa364"},{"key":"CIT0041","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-021-01688-9"},{"key":"CIT0042","doi-asserted-by":"publisher","DOI":"10.1002\/art.41277"},{"key":"CIT0043","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2004.10.5.423"},{"issue":"10","key":"CIT0044","first-page":"741","volume":"16","author":"Gellad WCB","year":"2010","journal-title":"Am J Manag Care"},{"key":"CIT0045","doi-asserted-by":"publisher","DOI":"10.18553\/jmcp.2016.14251"},{"key":"CIT0046","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-020-01472-1"},{"key":"CIT0047","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjz203.455"},{"key":"CIT0048","doi-asserted-by":"crossref","unstructured":"Pernes TPM, Khan N, Crescenz MJ, P1597 (S0792). The Safety of Switching From Originator Infliximab or Biosimilar CT-P. 13 to SB2 Among a Nationwide Cohort of Inflammatory Bowel Disease Patients. ACG 2020 Annual Scientific Meeting; Virtual; 2020.","DOI":"10.14309\/01.ajg.0000705216.13543.4d"},{"key":"CIT0049","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.591134"},{"key":"CIT0050","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2020.0338"},{"key":"CIT0051","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-019-00395-w"},{"key":"CIT0052","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00970"},{"key":"CIT0053","doi-asserted-by":"publisher","DOI":"10.1016\/j.jval.2016.09.1351"},{"key":"CIT0054","doi-asserted-by":"publisher","DOI":"10.1093\/crocol\/otaa093"},{"key":"CIT0055","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-019-00998-3"},{"issue":"1","key":"CIT0056","first-page":"97","volume":"37","author":"Gibofsky A","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"CIT0057","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2019.17379"},{"key":"CIT0058","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2019.2990"},{"key":"CIT0059","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.7316"},{"key":"CIT0060","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.091461"},{"key":"CIT0061","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0000000000000409"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/03007995.2022.2037846","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T09:11:57Z","timestamp":1691745117000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/03007995.2022.2037846"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,18]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4,3]]}},"alternative-id":["10.1080\/03007995.2022.2037846"],"URL":"https:\/\/doi.org\/10.1080\/03007995.2022.2037846","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,18]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=icmo20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-09-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-01-18","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-02-18","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}